Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1167-1174

  Nakamura, Tomonori ^a   Terajima, Tomoko ^a   Ogata, Taeko ^a   Ueno, Koichi ^a   Hashimoto, Naotake ^b   Ono, Kageyoshi ^a   Yano, Shingo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

High fat diet; Insulin resistance; Model mouse; Nicotinamide; Streptozotocin; Type 2 diabetes

Indexed keywords

BUFORMIN; GLIBENCLAMIDE; NICOTINAMIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASIAN; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; WEIGHT REDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRUG SYNERGISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; NIACINAMIDE; PANCREAS; STREPTOZOCIN; WEIGHT GAIN;

EID: 33744918517     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1167     Document Type: Article

References (26)

1. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J. B., Bonadonna R. C., Muggeo M., Diabetes, 53, 1782-1789 (2004).
2. Lipson L. G., Am. J. Med., 80, 10-21 (1986).
3. Jaber L. A., Brown M. B., Hammad A., Zhu Q., Herman W. H., Diabetes Care, 27, 234-238 (2004).
4. Gelding S. V., Niththyananthan R., Chan S. P., Skinner E., Robinson S., Gray I. P., Mather H., Johnston D. G., Clin. Endocrinol. (Oxf.), 40, 55-62 (1994).
5. Junod A., Lambert A. E., Stauffacher W., Renold A. E., J. Clin. Invest., 48, 2129-2139 (1969).
6. Okamoto H., Yamamoto H., Princess Takamatsu Symp., 13, 297-308 (1983).
7. Yamamoto H., Uchigata Y., Okamoto H., Nature (London), 294, 284-286 (1981).
8. Giroix M. H., Nadi A. B., Sener A., Portha B., Malaisse W. J., Int. J. Mol. Med., 9, 381-384 (2002).
9. Anderson T., Schein P. S., McMenamin M. G., Cooney D. A., J. Clin. Invest., 54, 672-677 (1974).
10. Schein P. S., Cooney D. A., Vernon M. L., Cancer Res., 27, 2324-2332 (1967).
11. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., Ribes G., Diabetes, 47, 224-229 (1998).
12. Boivin A., Deshaies Y., Metabolism, 44, 1540-1547 (1995).
13. Tokuyama T., Yagui K., Yamaguchi T., Huang C. I., Kuramoto N., Shimada F., Miyazaki J., Horie H., Saito Y., Makino H., Kanatsuka A., Metabolism, 46, 1044-1051 (1997).
14. Harris R. B., Mitchell T. D., Hebert S., Exp. Biol. Med. (Maywood), 228, 24-32 (2003).
15. Kulkarni R. N., Almind K., Goren H. J., Winnay J. N., Ueki K., Okada T., Kahn C. R., Diabetes, 52, 1528-1534 (2003).
16. Lee K. U., Lee H. K., Koh C. S., Min H. K., Diabetologia, 31, 285-290 (1988).
17. Paik S. G., Fleischer N., Shin S. I., Proc. Natl. Acad. Sci. U.S.A., 77, 6129-6133 (1980).
18. Ito M., Kondo Y., Nakatani A., Hayashi K., Naruse A., Environ. Toxicol. Pharmacol., 9, 71-78 (2001).
19. Bolinder J., Gunnarsson R., Tyden G., Brattstrom C., Ostman J., Groth C. G., Transplant. Proc., 20, 475-478 (1988).
20. Sun A. M., Coddling J. A., Haist R. E., Diabetes, 23, 424-432 (1974).
21. Kendall D. M., Sutherland D. E., Najarian J. S., Goetz F. C., Robertson R. P., N. Engl. J. Med., 322, 898-903 (1990).
22. Hotta N., Komori T., Kobayashi M., Sakakibara F., Koh N., Sakamoto N., Diabetes Res. Clin. Pract., 19, 49-58 (1993).
23. Schmid-Antomarchi H., De Weille J., Fosset M., Lazdunski M., J. Biol. Chem., 262, 15840-15844 (1987).
24. Tokuyama Y., Sakurai K., Yagui K., Hashimoto N., Saito Y., Kanatsuka A., Metabolism, 50, 812-818 (2001).
25. Hara H., Egusa G., Yamakido M., Diabet. Med., 13, S133-S142 (1996).
26. Nagasaka S., Aiso Y., Yoshizawa K., Ishibashi S., Diabet. Med., 21, 136-141 (2004).